Status:
COMPLETED
Clinical Validation of NAVOY® Acute Kidney Injury in Swedish ICU Patients
Lead Sponsor:
AlgoDx
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The study aims to evaluate the performance of the prediction algorithm NAVOY® AKI in a Swedish adult ICU patient population versus fulfilment of KDIGO diagnostic criteria.
Eligibility Criteria
Inclusion
- The study will only include the subjects from the SEP-SE-02 study population. (NCT04570618)
Exclusion
- None
Key Trial Info
Start Date :
December 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT05424874
Start Date
December 2 2020
End Date
November 1 2021
Last Update
December 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensiv- och perioperativ vård
Malmo, Sweden, 20502